What is ADMA Biologics's quick ratio?

ADMA Biologics (ADMA) reported quick ratio of 3.9× in Q1 2026.

How has ADMA Biologics's quick ratio changed year-over-year?

ADMA Biologics's quick ratio increased by 17.1% year-over-year, from 3.4× to 3.9×.

What is the long-term trend for ADMA Biologics's quick ratio?

Over 5 years (2020 to 2025), ADMA Biologics's quick ratio has grown at a 0.7% compound annual growth rate (CAGR), from 3.6× to 3.7×.

What does quick ratio mean?

Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.

ADMA Biologics ADMA Quick ratio

Quick ratio at other companies

AbCellera Biologics Inc.ABCL

13.9×+3.7×

AnaptysBio, Inc.ANAB

7.6×-0.7×

ZymeworksZYME

10.8×+6.1×

Bio-Rad LaboratoriesBIO

2.4×-2.1×

Apogee Therapeutics, Inc.APGE

32.6×+16.8×

Quest DiagnosticsDGX

1.1×-0.2×

Other financials

Income statement

See full

Revenue$114.5M-0.3%

Gross profit$80.8M+32.2%

Operating income$58.3M+67.1%

Net income$45.3M+68.5%

EPS (diluted)$0.19+72.7%

Balance sheet

See full

Cash & equivalents$138.2M+92.9%

Total debt$204.4M+2,055%

Total equity$390.3M+4.5%

Total assets$665.2M+30.3%

Cash flow

See full

Operating cash flow$58.2M+396%

CapEx$2.5M-45.9%

Free cash flow$55.7M+329%

Valuation

See full

Market cap$2.02B-54.5%

Profitability

See full

Gross margin61.3%+8.7pp

Operating margin42.1%+9.0pp

Net margin32.4%-12.6pp

FCF margin21.2%+1.4pp

Returns & leverage

See full

Return on equity43.3%-35.2pp

Debt / equity0.5×+0.5×

Current ratio7×+0.4×

Where this comes from

Calculated from ADMA Biologics’s reported figures.

quick assets/total current liabilities=3.9×

Based on the most recent quarter.

The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about ADMA Biologics's quick ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ADMA Biologics's quick ratio?: ADMA Biologics (ADMA) reported quick ratio of 3.9× in Q1 2026.
How has ADMA Biologics's quick ratio changed year-over-year?: ADMA Biologics's quick ratio increased by 17.1% year-over-year, from 3.4× to 3.9×.
What is the long-term trend for ADMA Biologics's quick ratio?: Over 5 years (2020 to 2025), ADMA Biologics's quick ratio has grown at a 0.7% compound annual growth rate (CAGR), from 3.6× to 3.7×.
What does quick ratio mean?: Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.